E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-20
DOI
10.1007/s00259-021-05245-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA
- (2020) Lorenzo Bianchi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
- (2020) Stefano Fanti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
- (2019) Wolfgang P. Fendler et al. JAMA Oncology
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
- (2019) Marlon Perera et al. EUROPEAN UROLOGY
- A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
- (2019) Etienne Rousseau et al. JOURNAL OF NUCLEAR MEDICINE
- Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer
- (2019) M. Wondergem et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy
- (2019) Isabel Rauscher et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga-PSMA-11 PET Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study
- (2019) Andrea Farolfi et al. JOURNAL OF UROLOGY
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
- (2019) Jeremie Calais et al. LANCET ONCOLOGY
- Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers—Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT
- (2019) Rudolf A. Werner et al. Journal of Clinical Medicine
- Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
- (2019) Wolfgang P Fendler et al. CLINICAL CANCER RESEARCH
- Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer
- (2019) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
- (2019) Clemens Kratochwil et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of three interpretation criteria of 68Ga-PSMA11 PET based on inter- and intra-reader agreement
- (2019) Akira Toriihara et al. JOURNAL OF NUCLEAR MEDICINE
- TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)
- (2019) Michael S. Hofman et al. BJU INTERNATIONAL
- Proposal of Systemic Therapy Response Assessment Criteria in time of PSMA PET/CT imaging: PSMA PET Progression (PPP)
- (2019) Stefano Fanti et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC (PSMA-11) in tumor and normal tissue
- (2019) Janet Pollard et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
- (2019) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
- (2018) Kambiz Rahbar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy
- (2018) Isabel Rauscher et al. EUROPEAN UROLOGY
- Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- (2018) Sangwon Han et al. EUROPEAN UROLOGY
- A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
- (2018) Denise S. O’Keefe et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study
- (2018) Mikhail Kesler et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA-HBED-CC uptake in cervical, coeliac and sacral ganglia as an important pitfall in prostate cancer PET imaging
- (2018) Christoph Rischpler et al. JOURNAL OF NUCLEAR MEDICINE
- [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
- (2018) Michael S Hofman et al. LANCET ONCOLOGY
- 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
- (2018) Julia Corfield et al. WORLD JOURNAL OF UROLOGY
- 68Ga PSMA PET/CT predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate and high-risk prostate cancer
- (2018) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY).
- (2018) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection efficacy of [18F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy
- (2018) Frederik L. Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer
- (2018) Emmanouil Panagiotidis et al. CLINICAL NUCLEAR MEDICINE
- Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis
- (2018) Ricardo Pereira Mestre et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- 68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy
- (2018) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies
- (2018) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Discovery of 18F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions
- (2018) Boris D. Zlatopolskiy et al. JOURNAL OF NUCLEAR MEDICINE
- Meta-analysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology
- (2018) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Rapid modulation of PSMA expression by Androgen deprivation: Serial 68Ga PSMA-11 PET in men with hormone sensitive and castrate resistant prostate cancer commencing androgen blockade.
- (2018) Louise M Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
- (2018) Katharina Lückerath et al. EJNMMI Research
- Therapy assessment in prostate cancer using choline and PSMA PET/CT
- (2017) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
- (2017) Sara Sheikhbahaei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
- (2017) Wolfgang P. Fendler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
- (2017) Stefano Fanti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
- (2017) Charalambos Kaittanis et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Utility of 68 Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma
- (2017) Shankar Siva et al. Journal of Medical Imaging and Radiation Oncology
- Intraindividual Comparison of18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
- (2017) Claudia Kesch et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
- (2017) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
- (2016) S. Gillessen et al. ANNALS OF ONCOLOGY
- Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT
- (2016) Refik Bilgin et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease
- (2016) Arun Sasikumar et al. CLINICAL NUCLEAR MEDICINE
- Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT
- (2016) Benjamin Noto et al. CLINICAL NUCLEAR MEDICINE
- Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer
- (2016) Christian H. Pfob et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
- (2016) Frederik L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
- (2016) Matthias Eiber et al. EUROPEAN UROLOGY
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
- (2016) Lars Budäus et al. EUROPEAN UROLOGY
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- Biodistribution of [68Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions
- (2016) Vikas Prasad et al. MOLECULAR IMAGING AND BIOLOGY
- 68Ga-PSMA imaging of metastatic breast cancer
- (2015) Mike Sathekge et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research
- (2013) Benjamin T. Ristau et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
- (2012) Alejandro Sanchez-Crespo APPLIED RADIATION AND ISOTOPES
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
- (2012) Matthias Eder et al. BIOCONJUGATE CHEMISTRY
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
- (2008) R. C. Mease et al. CLINICAL CANCER RESEARCH
- Prostate-specific membrane antigen expression in regeneration and repair
- (2008) Ilyssa O Gordon et al. MODERN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started